Company Active PRIVATE-LIMITED-GUARANT-NSC-LIMITED-EXEMPTION

Company profile

Moredun Research Institute

UK company SC149440, incorporated on 1 March 1994.

Moredun is committed to promoting livestock health and welfare through research and education. | Moredun

Moredun Research Institute is a UK company with status Active founded in 1994 based in Scotland.

Company number
SC149440
Incorporated
1 Mar 1994
Companies House status
Active

Company identity

Founded / incorporated
1 March 1994

Company number SC149440

Verify at Companies House
Legal name
MOREDUN RESEARCH INSTITUTE
Company type
PRI/LBG/NSC (Private, Limited by guarantee, no share capital, use of 'Limited' exemption)
Region
Scotland
Registered address
PENTLANDS SCIENCE PARK
BUSH LOAN
PENICUIK
MIDLOTHIAN
EH26 0PZ
Insolvency history
No

Corporate ownership

Updated 07 Jul 2026 09:49

1 level 1 ultimate controller Controls 6
1
Company Active PRIVATE-LIMITED-GUARANT-NSC-LIMITED-EXEMPTION
Moredun Research Institute
CRN SC149440
2
Direct and ultimate controller Active PRIVATE-LIMITED-GUARANT-NSC-LIMITED-EXEMPTION
The Moredun Foundation
CRN SC151865

Company events

Reference milestones and recent Companies House filing stream events.

5 events
15 Mar
2027

Confirmation statement due

Confirmation Due

Next confirmation statement due date

31 Dec
2026

Accounts due

Accounts Due

Next accounts due date

01 Mar
2026

Confirmation statement filed

Confirmation

Last confirmation statement made up date

31 Mar
2025

Accounts filed

Accounts

Last accounts made up date

01 Mar
1994

Incorporated

Inception

Company registered at Companies House

Public funding

4 awards
First funded
2012
Funded years
2012, 2016, 2019
Age at first award
17 years

Projects

2019 Collaborative R&D

Multifunctionalized Microalgae (MM) - A novel and flexible platform technology for maximising feed/energy conversion ratios and treating severe infections in livestock

1 Mar 2019 to 30 Sep 2022

Awarded
£68,010
Total cost £68,010

Production-purpose antibiotics are one of the great Faustian bargains of the modern era: mankind has traded increased livestock yields today for AMR tomorrow. We propose that microalgae can be readily engineered to express a wide range of naturally occurring antimicrobial and anti-inflammatory compounds which can both substitute for production-purpose ant...

2016 BIS-Funded Programmes Lead participant

Pan-specific vaccine to control Streptococcus agalactiae disease in tilapia aquaculture

1 Apr 2016 to 30 Sep 2017

Awarded
£174,749
Total cost £174,749

As the world population grows and becomes more affluent, an increasing number of people include protein in their diet. Aquaculture is the fastest growing source of animal protein and a major source of income in Asia, South-America and Africa. Tilapia is a popular fish, both with farmers and consumers, but disease can cause massive losses on tilapia farms....

2012 Collaborative R&D

Development of a novel sea louse vaccine: an environmentally friendly tool for increasing sustainability of protein production in UK salmon aquaculture

1 Feb 2012 to 30 Apr 2016

Awarded
£431,162
Total cost £431,162

UK Atlantic salmon aquaculture produces 150,000 tonnes of fish per year, with high quality food products valued at more than £1 billion in retail sales. Sea lice, parasitic crustaceans infecting salmon in the sea, are a key constraint to the sustainability of farmed salmon protein production, costing UK industry more than £30 million per year to control. ...

2012 Feasibility Studies

Assessment of the use of Microwave Volumetric Heating to inactivate MAP

1 Feb 2012 to 30 Nov 2012

Awarded
£18,408
Total cost £18,408

Microwave volumetric heating (MVH), a unique technology developed by Advanced Microwave Technology (AMT) Ltd for pasteurising liquids, has the potential to inactivate Mycobacterium avium subspecies paratuberculosis (MAP). The key objectives are: 1. To determine MVH thermal inactivation curves for MAP in phosphate buffered saline, 2. To investigate inactiv...

Product types

BIS-Funded Programmes Collaborative R&D Feasibility Studies